TMCnet News
ConvergeHEALTH by Deloitte Launches Patient-Centered Digital Health Platform to Support Global Clinical Trials at SCOPE Summit 2020ORLANDO, Fla., Feb. 18, 2020 /PRNewswire/ -- ConvergeHEALTH by Deloitte today announced the launch of MyPATH for Clinical, a cloud-based digital platform designed to enhance the patient experience as well as the success and efficiency of global clinical trials. MyPATH for Clinical is a modular, patient-centric platform that can help accelerate the execution of digital clinical trials by taking a holistic approach to connect clinical trial participants, investigators and clinical research associates. It leverages modern cloud, mobile and connected medical device technologies to address three core industry challenges: patient recruitment; patient engagement to drive retention; and protocol management. "The adoption of technology in clinical trials has focused primarily on the administrative, data capture and data management aspects of running a trial. We are launching MyPATH for Clinical with the goal of leveraging modern cloud, mobile, and wearable digital technologies to fundamentally transform the patient and investigator experience in clinical trials," said Brett Davis, principal, Deloitte Consulting LLP, and general manager, ConvergeHEALTH by Deloitte. "As the clinical trial model transforms, we hope to help improve recruitment approaches, reduce dropout rates and increase patient support during the trial for better protocol compliance." MyPATH for Clinical enables:
MyPATH for Clinical lays the foundation for digitizing clinical trials while enhancing patient and investigator engagement by providing education and resources; medication tracking and appointment management; symptom tracking; patient reported outcomes and surveys; and data visualization for patients. It also supports investigators by providing direct connectivity while organizing patient data into helpful dashboards. This improves the experience for patients and investigators, and enables research teams to generate new insights and provide better patient support while in a trial. "Recruiting and retaining patients, and lack of protocol compliance are huge hurdles in today's clinical trials," said Dawn Anderson, managing director, Deloitte Consulting LLP. "As advances in technology are coupled with the needs of an evolving, maturing clinical research data requirements, clinical trials must adapt. MyPATH for Clinical can help patients, investigators and CRAs navigate the changes necessary to be successful in digitizing the clinical trials of the future." For more information, stop by Deloitte booth #817 at the SCOPE Summit in Orlando, Feb. 18-21, 2010, or visit the ConvergeHEALTH website. About Deloitte Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee ("DTTL"), its network of member firms, and their related entities. DTTL and each of its member firms are legally separate and independent entities. DTTL (also referred to as "Deloitte Global") does not provide services to clients. In the United States, Deloitte refers to one or more of the US member firms of DTTL, their related entities that operate using the "Deloitte" name in the United States and their respective affiliates. Certain services may not be available to attest clients under the rules and regulations of public accounting. Please see www.deloitte.com/about to learn more about our global network of member firms. View original content to download multimedia:http://www.prnewswire.com/news-releases/convergehealth-by-deloitte-launches-patient-centered-digital-health-platform-to-support-global-clinical-trials-at-scope-summit-2020-301006584.html SOURCE Deloitte |